Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Breaks Ground on New Facility in India to Support Local Pharmas

NEW YORK (GenomeWeb News) — Thermo Fisher Scientific has broken ground on a $17 million facility in India designed to support its biopharmaceutical customers in the country.
 
Thermo Fisher said the 100,000-square-foot facility, located in the western city of Ahmadabad, will be responsible for packaging, distributing, and managing logistics for pharmaceutical samples that will be part of drug trials around the world.
 
The company expects to open the facility in the spring of 2008 and add approximately 100 employees in the first year of operation.
 
"Large pharmaceutical companies are focusing more and more on India for their future clinical research and development programs," Thermo Fisher CEO Marijn Dekkers said in a statement.
 
"They are looking to outsource their clinical trials management to partners who know how to work within changing regional and global clinical trial regulations,” he added.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.